8.98
price down icon0.33%   -0.03
after-market Dopo l'orario di chiusura: 8.87 -0.11 -1.22%
loading

Anavex Life Sciences Corporation Borsa (AVXL) Ultime notizie

pulisher
11:59 AM

Real time breakdown of Anavex Life Sciences Corp. stock performancePortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com

11:59 AM
pulisher
09:35 AM

Will Anavex Life Sciences Corp. stock split again soonInflation Watch & Proven Capital Preservation Tips - Trung tâm Dự báo KTTV quốc gia

09:35 AM
pulisher
09:27 AM

How Anavex Life Sciences Corp. stock valuations compare to rivalsTreasury Yields & Verified Swing Trading Watchlists - Trung tâm Dự báo KTTV quốc gia

09:27 AM
pulisher
06:24 AM

Can machine learning forecast Anavex Life Sciences Corp. recoveryRate Cut & Consistent Return Strategy Ideas - newser.com

06:24 AM
pulisher
Oct 16, 2025

Is Anavex Life Sciences Corp. stock resilient to inflation2025 Dividend Review & Reliable Breakout Stock Forecasts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Can Anavex Life Sciences Corp. stock deliver strong Q4 earningsJuly 2025 Selloffs & AI Driven Price Predictions - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How Anavex Life Sciences Corp. stock reacts to global recession fears2025 Market Overview & Daily Oversold Bounce Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Detecting price anomalies in Anavex Life Sciences Corp. with AI2025 Short Interest & Accurate Buy Signal Notifications - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How higher bond yields impact Anavex Life Sciences Corp. (12X1) stockVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Visualizing Anavex Life Sciences Corp. stock with heatmapsCEO Change & Free Community Consensus Stock Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Heatmap analysis for Anavex Life Sciences Corp. and competitors2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How strong is Anavex Life Sciences Corp. stock revenue growthPortfolio Value Summary & Long-Term Growth Plans - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Can trapped investors hope for a rebound in Anavex Life Sciences Corp.July 2025 Sentiment & Long-Term Safe Investment Plans - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’ - The Manila Times

Oct 10, 2025
pulisher
Oct 10, 2025

Anavex Life Sciences Corp. Announces Oral Presentation on Alzheimer's Disease Care at Alzheimer Europe Conference - Quiver Quantitative

Oct 10, 2025
pulisher
Oct 10, 2025

Oral Blarcamesine Presented at 35th Alzheimer Europe — Anavex Highlights ANAVEX®2-73-AD-004 IIb/III - Stock Titan

Oct 10, 2025
pulisher
Oct 10, 2025

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 260% Upside in the Biotechnology Sector - DirectorsTalk Interviews

Oct 10, 2025
pulisher
Oct 10, 2025

Will Anavex Life Sciences Corp. (12X1) stock keep high P E multiplesJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is Anavex Life Sciences Corp. (12X1) stock testing key supportWeekly Trade Report & Community Verified Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

HC Wainwright & Co. Reiterates Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq

Oct 07, 2025
pulisher
Oct 07, 2025

Anavex Life Sciences stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Oct 07, 2025
pulisher
Oct 05, 2025

Long term hold vs stop loss in Anavex Life Sciences Corp.Analyst Downgrade & Community Consensus Stock Picks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Tools to monitor Anavex Life Sciences Corp. recovery probabilityEarnings Risk Report & Advanced Technical Signal Analysis - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Anavex Life Sciences (NASDAQ:AVXL) Trading Up 8.7%Should You Buy? - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Anavex Life Sciences (Nasdaq:AVXL) Reports Positive Phase 2 Results for ANAVEX®3-71 in Schizophrenia - Kalkine Media

Oct 03, 2025
pulisher
Oct 02, 2025

D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq

Oct 02, 2025
pulisher
Oct 02, 2025

Is Anavex Life Sciences Corp a good long term investmentBollinger Bands Signals & Free Phenomenal Capital Appreciation - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex: ANAVEX 3-71 Could Potentially Offer Disease-Modifying Effects For Schizophrenia - Seeking Alpha

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences (NASDAQ:AVXL) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences (AVXL): Analyst Reaffirms "Buy" Rating | AV - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update - Stocktwits

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences (AVXL) Shares Rise on Positive Trial Result - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences Reports Positive Phase 2 Results for ANAVEX®3-71 in Schizophrenia Clinical Study Achieving Safety and Tolerability Endpoints - Quiver Quantitative

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program - The Manila Times

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - The Manila Times

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences stock rises after positive schizophrenia drug trial - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Develops Once-Daily Tablet for ANAVEX3-71 in Phase 1b Trial | AVXL Stock News - Stock Titan

Oct 02, 2025
pulisher
Oct 02, 2025

Novel Schizophrenia Drug ANAVEX3-71 Shows Promise: Safe Profile and Reduced Brain Inflammation Markers - Stock Titan

Oct 02, 2025
pulisher
Oct 02, 2025

Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World

Oct 02, 2025
pulisher
Oct 01, 2025

Alzheimer’s Disease Market: Epidemiology, Therapies, and Key Players | Anavex Life Sciences Corp., TauRx Therapeutics Ltd, BioVie Inc., AriBio Co., Ltd., Novo Nordisk A/S, AgeneBio, Neurim Pharmaceuti - Barchart.com

Oct 01, 2025
pulisher
Oct 01, 2025

Anavex Life Sciences (NASDAQ:AVXL) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

Alzheimer's Disease Market: Epidemiology, Therapies, And Key Players Anavex Life Sciences Corp., Taurx Therapeutics Ltd, Biovie Inc., Aribio Co., Ltd., Novo Nordisk A/S, Agenebio, Neurim Pharmaceuti - Menafn.com

Oct 01, 2025
pulisher
Oct 01, 2025

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial - markets.businessinsider.com

Oct 01, 2025
pulisher
Sep 30, 2025

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer's Disease Trial - Investing News Network

Sep 30, 2025
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):